New Stock News | Shenzhen Salubris Pharmaceuticals (002294.SZ) submits a listing application to the Hong Kong Stock Exchange.

21:15 12/02/2026

According to the disclosure on February 12 by the Hong Kong Stock Exchange, Shenzhen Xilantai Pharmaceutical Co., Ltd. (002294.SZ) submitted an application for listing on the main board of the Hong Kong Stock Exchange, with joint sponsors Goldman Sachs, Citigroup, and CITIC Securities.

According to the Hong Kong Stock Exchange disclosure on February 12, Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) has submitted an application for listing on the main board of the Hong Kong Stock Exchange, with joint sponsors including Goldman Sachs, Citigroup, and CITIC SEC. According to the prospectus, Shenzhen Salubris Pharmaceuticals is a pioneer in the field of cardiovascular-kidney-metabolic (cardiorenal metabolic syndrome) disease treatment in China. According to Frost & Sullivan data, by 2024 Shenzhen Salubris Pharmaceuticals is the second largest pharmaceutical company in China's cardiovascular innovative drug field in terms of revenue. As of the final practicable date, according to Frost & Sullivan data, Shenzhen Salubris Pharmaceuticals has the second largest innovative drug pipeline for cardiorenal metabolic syndrome among domestic companies in terms of scale.

Shanghai Huitong Energy (600605.SH) is planning to reduce its shareholdings by no more than 1% in Ningbo Hutong.

ANTON OILFIELD (03337) announced an expected annual profit attributable to shareholders of approximately 3.6 billion to 3.8 billion yuan in 2025, representing a year-on-year growth of 48.4% to 56.6%.

Shenke Slide Bearing Corporation (002633.SZ) plans to repurchase company shares in the amount of 40 to 80 million yuan.

Shanghai Huitong Energy (600605.SH) is planning to reduce its shareholdings by no more than 1% in Ningbo Hutong.

ANTON OILFIELD (03337) announced an expected annual profit attributable to shareholders of approximately 3.6 billion to 3.8 billion yuan in 2025, representing a year-on-year growth of 48.4% to 56.6%.

Shenke Slide Bearing Corporation (002633.SZ) plans to repurchase company shares in the amount of 40 to 80 million yuan.